Temozolomide is an antineoplastic chemotherapy drug used to treat certain types of brain tumors, including glioblastoma multiforme. It works by interfering with the growth of cancer cells and stopping them from dividing and spreading. It is usually prescribed in combination with radiation therapy. Common side effects of temozolomide include nausea, vomiting, headache, fatigue, and diarrhea.
Temozolomide, also known by the brand name Temodar, is a medication used to treat certain types of brain tumors. Here's a breakdown of its key features:
Use:
- Treats brain tumors like glioblastoma and anaplastic astrocytoma.
- May be used for other cancers in some cases.
How it Works:
- Classified as an alkylating agent, a type of chemotherapy medication.
- Works by interfering with the DNA of cancer cells.
- Disrupts the cancer cells' ability to copy their DNA, hindering their growth and division.
Administration:
- Taken by mouth as capsules or intravenously (through a vein).
Side Effects:
- Common side effects include nausea, vomiting, fatigue, constipation, hair loss, and headache.
- Can cause low blood cell counts, increasing the risk of infection or bleeding.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L01 Antineoplastic agents
L01A - Alkylating agents
L01AX Other alkylating agents
ATC Code
External Links
Temozolomide